Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer TherapiesSharyl J. Nass, Jonathan Phillips, Margie Patlak, National Cancer Policy Forum, Board on Health Care Services · First published 2015Open the Tome
Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer ResearchSharyl J. Nass, Heather Gorby, National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine · First published 2015Open the Tome
Contemporary Issues for Protecting Patients in Cancer ResearchInstitute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Margie Patlak, Sharyl J. Nass · First published 2014Open the Tome
Ensuring Patient Access to Affordable Cancer DrugsInstitute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Margie Patlak, Sharyl J. Nass · First published 2014Open the Tome
Reducing Tobacco-Related Cancer Incidence & MortalityErin Balogh, Margie Patlak, Sharyl J. Nass · First published 2013Open the Tome
Role of Obesity in Cancer Survival and RecurrenceInstitute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak · First published 2012Open the Tome
Implementing a National Cancer Clinical Trials System for the 21st CenturyBoard on Health Care Services, National Cancer Policy Forum, Margie Patlak, Sharyl J. Nass, Institute of Medicine · First published 2011Open the Tome
National Cancer Policy Summit : Opportunities and Challenges in Cancer Research and CareAnd Erin Margie Patlak Sharyl J Nass · First published 2011Open the Tome
Patient-Centered Cancer Treatment Planning : Improving the Quality of Oncology CareInstitute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Erin Balogh · First published 2011Open the Tome
Extending the Spectrum of Precompetitive Collaboration in Oncology ResearchInstitute of Medicine Staff, Sharyl J. Nass, Margie Patlak, Erin Balogh, Board on Health Care Services Staff · First published 2010Open the Tome
Extending the Spectrum of Precompetitive Collaboration in Oncology ResearchMargie Patlak, Sharyl J. L. Nass, Rapporteurs Erin Balogh · First published 2010Open the Tome
Beyond the HIPAA privacy ruleSharyl J. Nass, Laura A. Levit, Lawrence O. Gostin · First published 2009Open the Tome
Multi-center phase III clinical trials and NCI cooperative groupsMargie Patlak, Sharyl J. Nass, Christine Micheel · First published 2009Open the Tome
Improving the quality of cancer clinical trialsMargie Patlak, Sharyl J. Nass · First published 2008Open the Tome
Improving the Quality of Cancer Clinical TrialsInstitute of Medicine, National Cancer Policy Forum, Sharyl Nass, Margie Patlak · First published 2008Open the Tome
Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and TreatmentMargie Patlak, Sharyl Nass, National Cancer Policy Forum, Institute of Medicine · First published 2006Open the Tome
Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment : The State of the Science, Evaluation, Implementation, and EconomicsInstitute of Medicine, National Cancer Policy Forum, Sharyl Nass, Margie Patlak · First published 2006Open the Tome
